发明名称 |
Methods, agents and peptides for inducing an innate immune response in HIV vaccination |
摘要 |
The present invention relates to enhancing, modulating or stimulating the innate immune response to HIV-1 and other viral pathogens and to the modulation and application of immune modulators and peptides for HIV-1 or other pathogen vaccines. The invention provides methods and means to activate an innate response to HIV-1 utilizing or via the HIV capsid protein or peptide, including modulating the binding of cyclophilin A to HIV capsid protein and modulating the ability of HIV to activate the major innate transcription factor IRF3 and interferon. Methods and assays are provided for screening for compounds, agents, or peptides capable of enhancing or activating innate immune response, particularly to HIV-1. |
申请公布号 |
US9358281(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US201012925068 |
申请日期 |
2010.10.12 |
申请人 |
New York University |
发明人 |
Littman Dan;Manel Nicolas |
分类号 |
A61K39/21;A61P37/00;C12Q1/70;G01N33/569;C07K14/005;A61K39/12;A61K39/00 |
主分类号 |
A61K39/21 |
代理机构 |
Klauber & Jackson LLC |
代理人 |
Klauber & Jackson LLC |
主权项 |
1. A method for stimulating or enhancing innate immune response to HIV-1 comprising administering in an immunogenic composition HIV-1 viral particles comprising a Vpx protein and a replication defective HIV-1 vector encoding an HIV-1 Gag polypeptide (SEQ ID NO: 4), wherein the Vpx protein is fused to a Vpr protein in a Vpx-Vpr fusion protein comprising SEQ ID NO: 51 and the Vpr protein of the Vpx-Vpr fusion protein facilitates incorporation of the Vpx-Vpr fusion protein into the HIV-1 viral particles. |
地址 |
New York NY US |